f5341ab5dc9691e69650443e46c0f431
ANTI DCE (RH 1,2,3)
DIAGAST·IV·Ecuador ARCSA·Registered December 07, 2022
Device classification
- Risk class
- IV
- Product type
- In Vitro Diagnostic
- Brand name
- DIAGAST
- Commercial name
- 19-294 IVD Reagents/Kits, Immunohematology, Blood Pooling
Registration information
- Analysis ID
- f5341ab5dc9691e69650443e46c0f431
- Registration date
- December 07, 2022
- Expiration date
- December 07, 2027
Manufacturer
- Name
- DIAGAST
- City
- LOOS
- Country
- FRENCH
- Address
- 251 AVENUE EUGENE AVINNEE, 59120 LOOS- FRANCE
Product owner
- Name
- DIAGAST
- Country
- FRENCH
Authorized representative
- Address
- BARRIO JIPIJAPA STREET: ISLA FERNANDINA NO. N42-40 INTERSECCION ISLA TORTUGA
- Phone
- 2252800
Product use
ANTI-DCE (RH1,2,3) DETECTS THE PRESENCE OF AT LEAST ONE OF ERYTHROCYTE ANTIGENS: D (RH1), C (RH2) OR E (RH3).
About this record
Access comprehensive regulatory information for ANTI DCE (RH 1,2,3) in the Ecuador medical device market through Pure Global AI's free database. This IV medical device is registered under ARCSA ID f5341ab5dc9691e69650443e46c0f431 and manufactured by DIAGAST. The device was registered on December 07, 2022.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.